Crossmark Global Holdings Inc. Purchases 369 Shares of Maximus, Inc. (NYSE:MMS)

Crossmark Global Holdings Inc. lifted its position in Maximus, Inc. (NYSE:MMS) by 9.8% in the 3rd quarter, Holdings Channel reports. The fund owned 4,152 shares of the health services provider’s stock after acquiring an additional 369 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in Maximus were worth $387,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Assenagon Asset Management S.A. boosted its stake in Maximus by 151.6% during the second quarter. Assenagon Asset Management S.A. now owns 233,134 shares of the health services provider’s stock worth $19,980,000 after acquiring an additional 140,481 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund boosted its position in shares of Maximus by 942.9% in the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 323,300 shares of the health services provider’s stock worth $27,707,000 after purchasing an additional 292,300 shares in the last quarter. Tidal Investments LLC grew its stake in shares of Maximus by 238.9% in the 1st quarter. Tidal Investments LLC now owns 12,763 shares of the health services provider’s stock worth $1,071,000 after buying an additional 8,997 shares during the last quarter. SG Americas Securities LLC increased its position in Maximus by 609.6% during the 2nd quarter. SG Americas Securities LLC now owns 14,278 shares of the health services provider’s stock valued at $1,224,000 after buying an additional 12,266 shares in the last quarter. Finally, Vanguard Group Inc. raised its stake in Maximus by 2.4% during the first quarter. Vanguard Group Inc. now owns 6,208,839 shares of the health services provider’s stock valued at $520,922,000 after buying an additional 145,983 shares during the last quarter. Hedge funds and other institutional investors own 97.21% of the company’s stock.

Maximus Trading Down 2.3 %

NYSE MMS opened at $79.18 on Monday. Maximus, Inc. has a 12 month low of $76.42 and a 12 month high of $93.97. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.61. The stock’s fifty day moving average price is $89.02 and its 200-day moving average price is $88.22. The stock has a market cap of $4.77 billion, a P/E ratio of 16.60 and a beta of 0.77.

Maximus Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Saturday, November 30th. Investors of record on Friday, November 15th will be given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 1.52%. The ex-dividend date is Friday, November 15th. Maximus’s dividend payout ratio (DPR) is 25.16%.

Insider Buying and Selling at Maximus

In other Maximus news, insider Michelle F. Link sold 1,363 shares of Maximus stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $92.56, for a total value of $126,159.28. Following the completion of the sale, the insider now owns 6,567 shares of the company’s stock, valued at approximately $607,841.52. This trade represents a 17.19 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.40% of the stock is owned by company insiders.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.